Jackson Immuno Research Inc.
specializing in secondary antibodies and conjugates

Jackson ImmunoResearch Coronavirus Statement

Update from COO Dave Fancy PhD

20th March 2020

The outbreak of the novel coronavirus (Covid-19) presents significant challenges for everyone. As a key supplier for life science, Jackson ImmunoResearch has put policies in place to ensure the safety of our employees and the continuity of our manufacturing operations. We are following current guidelines from US Centers for Disease Control and the Governor of Pennsylvania.

Scientist in a medical laboratory with a dispenser in their hands doing an analysis

Jackson ImmunoResearch will remain open and does not foresee a disruption in our ability to deliver products. The vast majority of our products are available for shipment globally in our temperature stable lyophilized format. Please contact us if there are reagents we can supply during this time of increased demand for diagnostics. We currently have no supply chain issues, and will keep our customers informed if things change.

For specific information on particular products or if you have additional questions, please contact our customer service team at +1 800-367-5296. In the event additional restrictions are put in place and you are unable to receive your shipment, please notify our customer service team.

As always, we thank you for your business and are here to support your needs. Please stay safe as we continue to navigate this situation.

Best regards,
Dave Fancy Ph.D
Chief Operating Officer
Jackson ImmunoResearch